Targeting the Akt/PI3K signaling pathway as a potential therapeutic strategy for the treatment of pancreatic cancer

S Ebrahimi, M Hosseini, S Shahidsales… - Current medicinal …, 2017 - ingentaconnect.com
… with the pathologic grade of pancreatic cancer [13]. Ng and colleagues showed that PI3K
pathway is constitutively activated in pancreatic cancer cells and PI3K suppression increases …

[HTML][HTML] Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway

N Li, F Yang, DY Liu, JT Guo, N Ge… - World journal of …, 2021 - ncbi.nlm.nih.gov
… indicated that scoparone inhibits pancreatic cancer cell proliferation, migration, and
invasion, and induced cell cycle arrest and apoptosis through the PI3K/Akt signaling pathway. …

PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells

J Ma, H Sawai, N Ochi, Y Matsuo, D Xu… - Molecular and cellular …, 2009 - Springer
… Thus, in PTEN siRNA transfected pancreatic cancer cells, the PI3KAkt signaling pathway
was activated, subsequently enhancing VEGF expression and increasing eNOS activation. …

LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway

H Zhang, Y Pan, M Cheung, M Cao, C Yu, L Chen… - Cell death & …, 2019 - nature.com
… To elucidate whether inhibiting the PI3K/Akt signaling pathway … Inhibition of the PI3K/Akt
signaling pathway significantly … invasion via the PI3K/Akt signaling pathway. LAMB3 knockdown …

Targeting PI3K/AKT/mTOR signaling pathway in pancreatic cancer: from molecular to clinical aspects

S Stanciu, F Ionita-Radu, C Stefani, D Miricescu… - International journal of …, 2022 - mdpi.com
pancreatic cancer patients. In this review, we focus on PI3K/AKT/mTOR inhibitors that have
shown great anti-tumor potential in studies performed on xenograft models and pancreatic

Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway

X Xu, Y Yu, K Zong, P Lv, Y Gu - Journal of Experimental & Clinical Cancer …, 2019 - Springer
… the PI3K-Akt signaling pathway and promotes pancreatic cancer growth in vivo To determine
whether IGF2BP2 promotes pancreatic cancer cell growth via the PI3K-Akt pathway in vivo …

Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer

M Mortazavi, F Moosavi, M Martini, E Giovannetti… - Critical reviews in …, 2022 - Elsevier
PI3K/AKT/mTOR signaling pathway, a main downstream effector of KRAS is involved in the
PI3K/AKT/mTOR pathway could provide valuable assets for treatment of pancreatic cancer

Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter?

R Baer, C Cintas, N Therville… - Advances in biological …, 2015 - Elsevier
signalling pathway and in particular Class I PI3K isoforms for pancreatic cancer treatment.
Isoform-specificity of PI3K inhibitors are currently designed to achieve the same goal as pan-…

TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway

Y Fu, N Yao, D Ding, X Zhang, H Liu… - Journal of cellular …, 2020 - Wiley Online Library
… disclosed that activation of TGFβ1 and PI3K/AKT signal might be responsible for TMEM158‐…
TGFβ1 and PI3K/AKT signaling pathways, highlighting its potential as a tumor promoter and …

[HTML][HTML] Inhibition of PI3K/AKT signaling pathway radiosensitizes pancreatic cancer cells with ARID1A deficiency in vitro

L Yang, G Yang, Y Ding, Y Dai, S Xu, Q Guo… - … of cancer, 2018 - ncbi.nlm.nih.gov
… dependent, and down-regulated phosphorylation of AKT by LY294002 or mk2206 could …
role of PI3K/AKT signaling pathway on the radioresistance of pancreatic cancer cells induced by …